A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines.
about
Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV.Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide.In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents.Application of Pharmacokinetics Modelling to Predict Human Exposure of a Cationic Liposomal Subunit Antigen Vaccine System.
P2860
A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A physiologically-based pharma ...... ng adjuvant in human vaccines.
@en
A physiologically-based pharmacokinetic
@nl
type
label
A physiologically-based pharma ...... ng adjuvant in human vaccines.
@en
A physiologically-based pharmacokinetic
@nl
prefLabel
A physiologically-based pharma ...... ng adjuvant in human vaccines.
@en
A physiologically-based pharmacokinetic
@nl
P2860
P1476
A physiologically-based pharma ...... ng adjuvant in human vaccines.
@en
P2093
Million A Tegenge
Robert J Mitkus
P2860
P2888
P304
P356
10.1007/S10928-013-9328-Y
P577
2013-08-04T00:00:00Z